Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC3285298779;98780;98781 chr2:178539511;178539510;178539509chr2:179404238;179404237;179404236
N2AB3121193856;93857;93858 chr2:178539511;178539510;178539509chr2:179404238;179404237;179404236
N2A3028491075;91076;91077 chr2:178539511;178539510;178539509chr2:179404238;179404237;179404236
N2B2378771584;71585;71586 chr2:178539511;178539510;178539509chr2:179404238;179404237;179404236
Novex-12391271959;71960;71961 chr2:178539511;178539510;178539509chr2:179404238;179404237;179404236
Novex-22397972160;72161;72162 chr2:178539511;178539510;178539509chr2:179404238;179404237;179404236
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: G
  • RefSeq wild type transcript codon: GGT
  • RefSeq wild type template codon: CCA
  • Domain: Fn3-127
  • Domain position: 58
  • Structural Position: 88
  • Q(SASA): 0.2754
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
G/S None None 0.001 N 0.221 0.187 0.128392430309 gnomAD-4.0.0 1.59117E-06 None None None None N None 0 0 None 0 0 None 0 0 2.85825E-06 0 0
G/V rs1693340480 None 0.627 N 0.482 0.306 0.628842659243 gnomAD-4.0.0 1.59121E-06 None None None None N None 0 0 None 0 2.77254E-05 None 0 0 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
G/A 0.1964 likely_benign 0.1739 benign -0.287 Destabilizing 0.09 N 0.402 neutral N 0.428955663 None None N
G/C 0.3567 ambiguous 0.3167 benign -0.597 Destabilizing 0.928 D 0.586 neutral N 0.494353935 None None N
G/D 0.2154 likely_benign 0.2021 benign -0.158 Destabilizing 0.001 N 0.226 neutral N 0.441730172 None None N
G/E 0.2383 likely_benign 0.2133 benign -0.182 Destabilizing 0.008 N 0.324 neutral None None None None N
G/F 0.7625 likely_pathogenic 0.7317 pathogenic -0.593 Destabilizing 0.818 D 0.561 neutral None None None None N
G/H 0.5313 ambiguous 0.5076 ambiguous -0.664 Destabilizing 0.944 D 0.513 neutral None None None None N
G/I 0.5469 ambiguous 0.4963 ambiguous 0.085 Stabilizing 0.69 D 0.551 neutral None None None None N
G/K 0.5725 likely_pathogenic 0.5451 ambiguous -0.612 Destabilizing 0.241 N 0.45 neutral None None None None N
G/L 0.6242 likely_pathogenic 0.5777 pathogenic 0.085 Stabilizing 0.69 D 0.482 neutral None None None None N
G/M 0.6419 likely_pathogenic 0.605 pathogenic -0.205 Destabilizing 0.981 D 0.553 neutral None None None None N
G/N 0.2713 likely_benign 0.2523 benign -0.446 Destabilizing 0.241 N 0.403 neutral None None None None N
G/P 0.9287 likely_pathogenic 0.9227 pathogenic 0.001 Stabilizing 0.818 D 0.49 neutral None None None None N
G/Q 0.4161 ambiguous 0.3982 ambiguous -0.493 Destabilizing 0.69 D 0.45 neutral None None None None N
G/R 0.5123 ambiguous 0.4831 ambiguous -0.464 Destabilizing 0.627 D 0.494 neutral N 0.405945517 None None N
G/S 0.1383 likely_benign 0.1256 benign -0.765 Destabilizing 0.001 N 0.221 neutral N 0.392821504 None None N
G/T 0.2268 likely_benign 0.2064 benign -0.676 Destabilizing 0.241 N 0.432 neutral None None None None N
G/V 0.3582 ambiguous 0.3106 benign 0.001 Stabilizing 0.627 D 0.482 neutral N 0.440538093 None None N
G/W 0.6294 likely_pathogenic 0.6016 pathogenic -0.963 Destabilizing 0.981 D 0.603 neutral None None None None N
G/Y 0.606 likely_pathogenic 0.5629 ambiguous -0.467 Destabilizing 0.818 D 0.56 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.